These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 28253984)

  • 1. Therapeutic Strategies for Mitochondrial Dysfunction and Oxidative Stress in Age-Related Metabolic Disorders.
    Bhatti JS; Kumar S; Vijayan M; Bhatti GK; Reddy PH
    Prog Mol Biol Transl Sci; 2017; 146():13-46. PubMed ID: 28253984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.
    Bhatti JS; Bhatti GK; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1066-1077. PubMed ID: 27836629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies.
    Elfawy HA; Das B
    Life Sci; 2019 Feb; 218():165-184. PubMed ID: 30578866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioenergetics and mitochondrial dysfunction in aging: recent insights for a therapeutical approach.
    Romano AD; Greco E; Vendemiale G; Serviddio G
    Curr Pharm Des; 2014; 20(18):2978-92. PubMed ID: 24079772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging.
    Wang CH; Wu SB; Wu YT; Wei YH
    Exp Biol Med (Maywood); 2013 May; 238(5):450-60. PubMed ID: 23856898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
    Millichap LE; Damiani E; Tiano L; Hargreaves IP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of mitochondrial oxidative stress to hypertension.
    Dikalov SI; Dikalova AE
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):73-80. PubMed ID: 26717313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review.
    Kim SH; Kim H
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30134611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria in metabolic disease: getting clues from proteomic studies.
    Peinado JR; Diaz-Ruiz A; Frühbeck G; Malagon MM
    Proteomics; 2014 Mar; 14(4-5):452-66. PubMed ID: 24339000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mitochondrial dysfunction and dysregulation of Ca
    Wang CH; Wei YH
    J Biomed Sci; 2017 Sep; 24(1):70. PubMed ID: 28882140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease.
    Cojocaru KA; Luchian I; Goriuc A; Antoci LM; Ciobanu CG; Popescu R; Vlad CE; Blaj M; Foia LG
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Dysfunction in Age-Related Metabolic Disorders.
    Natarajan V; Chawla R; Mah T; Vivekanandan R; Tan SY; Sato PY; Mallilankaraman K
    Proteomics; 2020 Mar; 20(5-6):e1800404. PubMed ID: 32131138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
    Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of mitochondria on cardiometabolic syndromes.
    Anupama N; Sindhu G; Raghu KG
    Fundam Clin Pharmacol; 2018 Aug; 32(4):346-356. PubMed ID: 29453877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and mitochondrial dysfunction in neurodegeneration.
    Tritschler HJ; Packer L; Medori R
    Biochem Mol Biol Int; 1994 Aug; 34(1):169-81. PubMed ID: 7849618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of drug-based neuroprotection targeting mitochondria.
    Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P
    Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases.
    Serviddio G; Romano AD; Cassano T; Bellanti F; Altomare E; Vendemiale G
    Curr Pharm Des; 2011; 17(20):2036-55. PubMed ID: 21718251
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.